Role of liver and spleen stiffness in predicting the recurrence of hepatocellular carcinoma after resection

被引:146
|
作者
Marasco, Giovanni [1 ]
Colecchia, Antonio [2 ]
Colli, Agostino [3 ]
Ravaioli, Federico [1 ]
Casazza, Giovanni [4 ]
Reggiani, Maria Letizia Bacchi [5 ]
Cucchetti, Alessandro [1 ]
Cescon, Matteo [1 ]
Festi, Davide [1 ]
机构
[1] Univ Bologna, Dept Med & Surg Sci, Bologna, Italy
[2] Univ Hosp Borgo Trento, Gastroenterol Unit, Ple A Stefani 1, I-37126 Verona, Italy
[3] A Manzoni Hosp ASST Lecco, Dept Internal Med, Lecce, Italy
[4] Univ Milan, Dipartimento Sci Biomed & Clin L Sacco, Milan, Italy
[5] Univ Bologna, Dept Expt Diagnost & Specialty Med, Bologna, Italy
关键词
Hepatocellular carcinoma recurrence; Liver resection; Liver stiffness measurement; Spleen stiffness measurement; Portal hypertension; LATE INTRAHEPATIC RECURRENCE; HCV-RELATED CIRRHOSIS; RISK-FACTORS; PORTAL-HYPERTENSION; ESOPHAGEAL-VARICES; MICROVASCULAR INVASION; CURATIVE RESECTION; EFSUMB GUIDELINES; ALPHA-FETOPROTEIN; CLINICAL-USE;
D O I
10.1016/j.jhep.2018.10.022
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background & Aims: Hepatocellular carcinoma (HCC) is a frequent complication of liver disease. When feasible, hepatic resection is the first-choice therapy. However, tumor recurrence complicates at least 2/3 hepatic resections at 5 years. Early recurrences are mainly tumor or treatment-related, but predictors of late recurrences are undefined. We aimed to evaluate the factors related to HCC recurrence after curative resection, with liver and spleen stiffness measurement (LSM and SSM) as markers of severity and duration of the underlying liver disease. Methods: We enrolled patients with chronic liver disease and primary HCC suitable for hepatic resection. We followed up patients for at least 30 months or until HCC recurrence. We performed uni- and multivariate analyses to evaluate the predictive role of tumor characteristics, laboratory data, LSM and SSM for both early and late recurrence of HCC. Results: We prospectively enrolled 175 patients. Early HCC recurrence at multivariate analysis was associated with viral etiology, HCC grading (3 or 4), resection margins <1 cm and being beyond the Milan criteria. HCC late recurrence at univariate analysis was associated with esophageal varices (hazard ratio [HR] 3.321, 95% CI 1.564-7.053), spleen length (HR 3.123, 95% CI 1.377-7.081), platelet/spleen length ratio if <909 (HR 2.170, 95% CI 1.026-4.587), LSM (HR 1.036, 95% CI 1.005-1.067), SSM (HR 1.046, 95% CI 1.020-1.073). HCC late recurrence at multivariate analysis was independently associated only with SSM (HR 1.046, CI 1.020-1.073). Late HCC recurrence-free survival was significantly different according to the SSM cut-off of 70 kPa (p = 0.0002). Conclusions: SSM seems to be the only predictor of late HCC recurrence, since it is directly correlated with the degree of liver disease and portal hypertension, both of which are involved in carcinogenesis. Lay summary: The main result of this study is that spleen stiffness measurement, evaluated by transient elastography, seems to be the only predictor of the late recurrence of hepatocellular carcinoma, defined as recurrence after 24 months from liver resection. Indeed, spleen stiffness measurement is directly correlated with the degree of liver disease and portal hypertension, which are both involved in carcinogenesis. (C) 2018 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:440 / 448
页数:9
相关论文
共 50 条
  • [11] Prediction of Recurrence after Curative Resection of Hepatocellular Carcinoma using Liver Stiffness Measurement (FibroScanA®)
    Jung, Kyu Sik
    Kim, Seung Up
    Choi, Gi Hong
    Park, Jun Yong
    Park, Young Nyun
    Kim, Do Young
    Ahn, Sang Hoon
    Chon, Chae Yoon
    Kim, Kyung Sik
    Choi, Eun Hee
    Choi, Jin Sub
    Han, Kwang-Hyub
    ANNALS OF SURGICAL ONCOLOGY, 2012, 19 (13) : 4278 - 4286
  • [12] Role of inflammatory markers in predicting hepatocellular carcinoma recurrence after liver transplantation
    Badwei, Nourhan
    Monsef, Waheed A.
    Montasser, Iman
    Bahaa, Mohamed
    El Meteini, Mahmoud
    Kamel, Shimaa Y.
    EGYPTIAN LIVER JOURNAL, 2021, 11 (01)
  • [13] Role of inflammatory markers in predicting hepatocellular carcinoma recurrence after liver transplantation
    Nourhan Badwei
    Waheed A. Monsef
    Iman Montasser
    Mohamed Bahaa
    Mahmoud El Meteini
    Shimaa Y. Kamel
    Egyptian Liver Journal, 11
  • [14] A nomogram for predicting recurrence of primary hepatocellular carcinoma after resection
    Dai, Yunlong
    Feng, Qingbo
    Huang, Jiwei
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2023, 14 (04) : 1900 - 1901
  • [15] Liver transplantation for recurrence after resection of solitary hepatocellular carcinoma
    Majno, PE
    Adam, R
    Mazzaferro, V
    Regalia, E
    Mentha, G
    Moret, P
    Bismuth, H
    TRANSPLANTATION, 1999, 67 (09) : S579 - S579
  • [16] Recurrence of hepatocellular carcinoma after liver transplantation: Is there a place for resection?
    Fernandez-Sevilla, Elena
    Allard, Marc-Antoine
    Selten, Jasmijn
    Golse, Nicolas
    Vibert, Eric
    Cunha, Antonio Sa
    Cherqui, Daniel
    Castaing, Denis
    Adam, Rene
    LIVER TRANSPLANTATION, 2017, 23 (04) : 440 - 447
  • [17] Isolated Peritoneal Recurrence After Liver Resection for Hepatocellular Carcinoma
    Pandit, Narendra
    Awale, Laligen
    Chaudhary, Sameer
    Shah, Rajan
    Adhikary, Shailesh
    JOURNAL OF GASTROINTESTINAL CANCER, 2019, 50 (03) : 678 - 680
  • [18] Isolated Peritoneal Recurrence After Liver Resection for Hepatocellular Carcinoma
    Narendra Pandit
    Laligen Awale
    Sameer Chaudhary
    Rajan Shah
    Shailesh Adhikary
    Journal of Gastrointestinal Cancer, 2019, 50 : 678 - 680
  • [19] Factors predicting early recurrence after surgical resection of hepatocellular carcinoma
    Zhang, Yao-Ming
    Zhou, Zhen-Tao
    Liu, Gao-Min
    JOURNAL OF HEPATOLOGY, 2019, 70 (03) : 571 - 572
  • [20] Recurrence after resection of hepatocellular carcinoma
    J-MRegimbeau
    J.Belghiti
    Hepatobiliary&PancreaticDiseasesInternational, 2002, (03) : 401 - 405